[HNF-1alpha G319S mutation in Oji-Cree type 2 diabetes].
Yamagata
Kazuya
K
Department of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University.
D019943:Amino Acid Substitution / Q000235:genetics; D002170:Canada; D004268:DNA-Binding Proteins / Q000737:chemistry / Q000235:genetics*; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis / Q000235:genetics* / Q000628:therapy; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D005998:Glycine; D051537:Hepatocyte Nuclear Factor 1; D051538:Hepatocyte Nuclear Factor 1-alpha; D006801:Humans; D007198:Indians, North American; D008019:Life Style; D020125:Mutation, Missense; D009687:Nuclear Proteins / Q000737:chemistry / Q000235:genetics*; D009864:Ontario; D011379:Prognosis; D012694:Serine; D014157:Transcription Factors / Q000737:chemistry / Q000235:genetics*
D004268:DNA-Binding Proteins; C496487:HNF1A protein, human; D051538:Hepatocyte Nuclear Factor 1-alpha; D009687:Nuclear Proteins; D014157:Transcription Factors; D051537:Hepatocyte Nuclear Factor 1; D012694:Serine; D005998:Glycine